The local side effects of inhaled corticosteroids: Current understanding and review of the literature

Chest

Volumn 126, Issue 1, 2004, Pages 213-219

  Roland, Nicholas J ^a   Bhalla, Rajiv K ^a   Earis, John ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Asthma; Corticosteroid; Inhaler; Laryngitis; Local side effects; Pharyngitis

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADRENAL SUPPRESSION; ASTHMA; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COUGHING; DOSE RESPONSE; DRUG MEGADOSE; DRY POWDER; DYSPHONIA; HOARSENESS; HUMAN; HYPERTROPHY; LARYNX DISORDER; METERED DOSE INHALER; OSTEOPOROSIS; PERIORAL DERMATITIS; PHARYNGITIS; PHARYNX DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SIDE EFFECT; SKIN BRUISING; THIRST; TONGUE;

EID: 3242734980     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.1.213     Document Type: Review

References (65)

1. Szelfler SJ, Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991; 88:147-165
2. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98:196-208
3. Schleimer RP. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990; 141:S59-S69
4. Taylor IK, Shaw RJ. The mechanism of action of corticosteroids in asthma. Respir Med 1993; 87:261-277
5. Barnes PJ. Effect of corticosteroids on airway hyper-responsiveness. Am Rev Respir Dis 1990; 141:S70-S76
6. Barnes PJ. Anti-inflammatory therapy for asthma. Annu Rev Med 1993; 44:229-242
7. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 1998; 157:S1-S53
8. Anonymous. The use of inhaled corticosteroids in adults with asthma. Drug Ther Bull 2000; 38:5-8
9. Toogood JH, Crilly RG, Jones G, et al. Effect of high-dose inhaled Budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 1988; 138:57-61
10. Packe GE, Douglas JG, McDonald AF, et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992; 47:414-417
11. Maxwell DL. Adverse effects of inhaled corticosteroids. Biomed Pharmacother 1990; 44:421-427
12. Capewell S, Reynolds S, Shuttleworth D, et al. Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ 1990; 300:1548-1551
13. Mak VH, Melchor R, Spiro SG. Easy bruising as a side effect of inhaled corticosteroids. Eur Respir J 1992; 5:1068-1074
14. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337:8-14
15. Garbe E, LeLorier J, Boivin J-F, et al. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997; 277:722-727
16. Williamson IJ, Matusiewicz SP, Brown PH et al. Frequency of voice problems and cough in patients using pressurised aerosol steroid preparations. Eur Respir J 1995; 8:590-592
17. Babu S, Samuel P. The effect of inhaled steroids on the upper respiratory tract. J Laryngol Otol 1988; 102:592-594
18. Williams AJ, Baghat MS, Stableforth DE, et al. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983; 38:813-821
19. Dubus JC, Marguet C, Deschildre, et al. Local side effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age and device. Allergy. 2001; 56:944-948
20. Held E, Ottervanger V, Petersen S, et al. Perioral dermatitis in children under steroid inhalation therapy. Ugeskr Laeger 1997; 157:7002-7003
21. Linder N, Kuint J, German B, et al. Hypertrophy of the tongue associated with inhaled steroid therapy in premature infants. J Pediatr 1995; 127:651-653
22. Inhaler devices for asthma. Drug Ther Bull 2000; 38:9-14
23. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993; 48:817-823
24. Selroos O, Backman R, Forsen KO, et al. Local side effects during 4-year treatment with inhaled corticosteroids: a comparison between pressurized metered-dose inhalers and Turbohaler. Allergy 1994; 49:888-890
25. Ayres JG, Lundback B, Harris TA. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma: International Study Group. Eur Respir J 1995; 8:579-586
26. Pauwells RA, Hargreave FE, Camus P, et al. A 1-year comparison of Turbuhaler versus pressurised metered-dose inhaler in asthmatic patients. Chest 1996; 110:53-57
27. Shaw NJ, Edmunds AT. Inhaled beclomethasone and oral candidiasis. Arch Dis Child 1986; 61:788-790
28. Agertoft L, Larsen FE, Pedersen S. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. Eur Respir J 1998; 12:130-135
29. Milne LJ, Crompton GK. Beclomethasone dipropionate and oropharyngeal candidiasis. BMJ 1974; 3:797-798
30. Vogt FC. The incidence of oral candidiasis with the use of inhaled corticosteroids. Ann Allergy 1979; 43:205-210
31. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered dose inhaler alone and with Aerochamber. J Allergy Clin Immumol 1988; 81:424-428
32. Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 1990; 141:S89-S96
33. Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 1971; 123:371-377
34. Dennis M, Itkin IH. Effectiveness and complications of aerosol dexamethasone phosphate in severe asthma. J Allergy Clin Immunol 1964; 35:70-76
35. McAllen MK, Kachanowski SJ, Shaw KM. Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment. BMJ 1974; 1:171-175
36. Cayton RM, Soutar CA, Stanford CF, et al. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 1974; 2:303-307
37. Kriz RJ, Chmelik F, doPico G, et al. A short-term double blind trial of aerosol triamcinolone acetonide in steroid dependent patients with severe asthma. Chest 1976; 69:455-456
38. Willey RF, Milne LJ, Crompton GK, et al. Beclomethasone dipropionate and oropharyngeal candidiasis. Br J Dis Chest 1976; 70:32-38
39. Pines A. Steroid aerosols in asthma. BMJ 1977; 1:518
40. Kriz RJ, Chmelik F, doPico G, et al. A one-year trial of triamcinolone acetonide in severe steroid-dependent asthma. Chest 1977; 72:36-44
41. Rowland V, Levine BE. Long-term trials of aerosol triamcinolone acetonide in steroid dependent asthma. Ariz Med 1977; 34:247-249
42. Sahay JN, Chatterjee SS, Stanbridge TN. Inhaled corticosteroid aerosols and candidiasis. Br J Dis Chest 1979; 73:164-168
43. Webb DR, Mullarkey MF, Freeman MI. Flunisolide in chronic bronchial asthma. Ann Allergy 1979; 42:80-82
44. Shim C, Williams MH. Cough and wheezing from beclomethasone aerosol. Chest 1987; 91:207-209
45. Bryant DH, Pepys J. Bronchial reactions to aerosol inhalant vehicle. BMJ 1976; 1:1319-1320
46. Autio P, Karjalainen J, Ristelli L, et al. Effects of an inhaled steroid on skin collagen synthesis of asthma patients in vivo. Am J Respir Crit Care Med 1996; 153:1172-1175
47. Toogood JH, Jennings B, Greenway RW, et al. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980; 65:145-153
48. Newman SP, Pavia D, Moren F. et al. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36:52-55
49. Newman SP, Weisz AWB, Talaee N, et al. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46:712-716
50. Lipworth BJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995; 50:105-110
51. Hendry A, Coote J, Black H. et al. Comparison of conventional metered dose inhaler and breath actuated inhaler in elderly patients. Int J Pharm Pract 1995; 3:115-118
52. Allen SC. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 1997; 26:83-86
53. Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986; 41:118-124
54. Molina MJ, Rowland FS. Stratospheric sink for chlorofluoromedianes: chlorine atom-catalysed destruction of ozone. Nature 1974; 249:810-812
55. Partridge MR, Woodcock AA, Sheffer AL, et al. Chlorofluorocarbon-free inhalers: are we ready for the change? Eur Respir J 1998; 11:1006-1008
56. Nation Health Service Executive. Phase out of CFC containing metered dose inhalers for the treatment of asthma and COPD. Health Service Circular. London, UK: Department of Health, 23rd October 1998; HSC Publication No. 1998/180
57. O'Callaghan C, Barry P. Spacer devices in the treatment of asthma. BMJ 1997; 314:1061-1062
58. Newman SP, Moren F, Pavia D, et al. Deposition of pressurised suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981; 124:317-320
59. Dolovich M, Ruffin R, Newhouse MT. Clinical evaluation of a simple demand inhalation device MDI aerosol delivery device. Chest 1983; 84:36-41
60. Toogood JH, Baskerville J, Jennings B, et al. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984; 129:723-729
61. The use of inhaled corticosteroids in asthma. Drug Ther Bull 1999; 37:73-77
62. British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London, British Association of Accident and Emergency Medicine, British Paediatric Respiratory Society, Royal College of Paediatrics and Child Health. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52(suppl):S1-21
63. Dewsbury NJ, Kenyon CJ, Newman SP. The effect of handling techniques on electrostatic charge on spacer devices: a correlation with in vitro particle size analysis. Int J Pharm 1996; 137:261-264
64. Pierart F, Wildhaber JH, Vrancken I, et al. Washing plastic containers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999; 13:673-678
65. Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbohaler. Arch Dis Child 1990; 65:308-319